Correction to: Oncogene
The original version of this article unfortunately contained a mistake. The following correction has therefore been made in the original: The word “orthopedic” was changed to “orthotopic” in subheading “Mammary gland orthotopic implantation” and in the first sentence of section “Mammary gland orthotopic implantation”: “The abilities of human breast cancer cell lines to form tumors in vivo were evaluated by performing mammary gland orthotopic implantation as described previously, further details can be found in the Supplementary Information [48].”
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kung, CP., Cottrell, K.A., Ryu, S. et al. Correction to: Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer. Oncogene 40, 2147 (2021). https://doi.org/10.1038/s41388-021-01669-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41388-021-01669-w
